Cargando…
The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity
COVID-19 outbreak is the biggest threat to human health in recent history. Currently, there are over 1.5 million related deaths and 75 million people infected around the world (as of 22/12/2020). The identification of virulence factors which determine disease susceptibility and severity in different...
Autores principales: | Ramirez Alvarez, Carlos, Kee, Carmon, Sharma, Ashwini Kumar, Thomas, Leonie, Schmidt, Florian I., Stanifer, Megan L., Boulant, Steeve, Herrmann, Carl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270430/ https://www.ncbi.nlm.nih.gov/pubmed/34181691 http://dx.doi.org/10.1371/journal.ppat.1009687 |
Ejemplares similares
-
Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells
por: Metz-Zumaran, Camila, et al.
Publicado: (2022) -
Single‐cell analyses reveal SARS‐CoV‐2 interference with intrinsic immune response in the human gut
por: Triana, Sergio, et al.
Publicado: (2021) -
Reovirus inhibits interferon production by sequestering IRF3 into viral factories
por: Stanifer, Megan L., et al.
Publicado: (2017) -
SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses
por: Straus, Marco R., et al.
Publicado: (2020) -
Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells
por: Stanifer, Megan L., et al.
Publicado: (2020)